Koshinski Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$579K Buy
1,300
+2
+0.2% +$890 0.04% 369
2025
Q1
$629K Sell
1,298
-59
-4% -$28.6K 0.05% 331
2024
Q4
$546M Buy
1,357
+45
+3% +$18.1M 0.05% 346
2024
Q3
$610K Sell
1,312
-14
-1% -$6.51K 0.05% 324
2024
Q2
$644K Buy
+1,326
New +$644K 0.06% 291
2024
Q1
Sell
-500
Closed -$203K 642
2023
Q4
$203K Sell
500
-1,004
-67% -$409K 0.03% 472
2023
Q3
$523K Sell
1,504
-56
-4% -$19.5K 0.06% 310
2023
Q2
$549K Buy
1,560
+71
+5% +$25K 0.06% 322
2023
Q1
$469K Buy
1,489
+10
+0.7% +$3.15K 0.05% 345
2022
Q4
$427K Buy
1,479
+14
+1% +$4.04K 0.04% 393
2022
Q3
$424K Sell
1,465
-122
-8% -$35.3K 0.05% 354
2022
Q2
$447K Sell
1,587
-220
-12% -$62K 0.04% 389
2022
Q1
$472K Sell
1,807
-404
-18% -$105K 0.04% 407
2021
Q4
$486K Buy
2,211
+201
+10% +$44.1K 0.04% 404
2021
Q3
$365K Sell
2,010
-449
-18% -$81.4K 0.03% 459
2021
Q2
$496K Sell
2,459
-644
-21% -$130K 0.06% 330
2021
Q1
$667K Buy
3,103
+675
+28% +$145K 0.07% 306
2020
Q4
$574K Buy
2,428
+341
+16% +$80.6K 0.07% 289
2020
Q3
$573 Sell
2,087
-241
-10% -$66 0.08% 264
2020
Q2
$676K Buy
2,328
+879
+61% +$255K 0.11% 224
2020
Q1
$345K Buy
1,449
+47
+3% +$11.2K 0.07% 318
2019
Q4
$307K Buy
+1,402
New +$307K 0.05% 400
2019
Q1
Sell
-2,887
Closed -$478K 464
2018
Q4
$478K Sell
2,887
-1,095
-27% -$181K 0.12% 217
2018
Q3
$767K Sell
3,982
-4,050
-50% -$780K 0.11% 247
2018
Q2
$1.37M Sell
8,032
-40
-0.5% -$6.8K 0.42% 76
2018
Q1
$1.32M Buy
+8,072
New +$1.32M 0.41% 80
2017
Q3
Sell
-1,709
Closed -$220K 370
2017
Q2
$220K Buy
+1,709
New +$220K 0.08% 332